Breadcrumb
NIH Guide: Weekly Index for December 6, 2024
Weekly NIH Funding Opportunities and Notices
December 6, 2024
Policy Notices
-
Standard Language for Developer Terms of Access in the Terms and Conditions of Award
(NOT-OD-25-021)Office of the Director, NIH
General Notices
-
NIA Clinical Research Enrollment Policy
(NOT-AG-24-081)National Institute on Aging
-
NIAMS Implementation of LOR Due Dates for Applications Requesting $500,000 or More in Direct Costs in Any Year (excluding consortium F&A)
(NOT-AR-24-022)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Recorded Pre-Application Webinar for Notices of Funding Opportunity PAR-25-240 and PAR-25-241: Tobacco, Alcohol, and Cannabis Policy Research for Health Equity
(NOT-CA-25-015)National Cancer Institute
-
Notice of Virtual Question & Answer Office Hours for Biomedical Research Environment & Sponsored Programs Administration Development (BRE-SPAD) Program Applicants
(NOT-GM-25-014)National Institute of General Medical Sciences
-
Notice of Expiration of PA-21-235, NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed)
(NOT-MH-25-085)National Institute of Mental Health
-
Notice of the Effectiveness and Services Trials Pre-Application Webinar for PAR-25-177, PAR-25-187, and PAR-25-285
(NOT-MH-25-105)National Institute of Mental Health
-
NIH Research Enhancement Award (R15): What You Need to Know and Recent Changes, January 30, 2025, Webinar Register Today!
(NOT-OD-25-037)Office of the Director, NIH
-
NIH Implementation of Funding Opportunity Goals Text in TAGGS to Comply with OMB Memorandum M-22-02 Reporting Requirements
(NOT-OD-25-041)National Institutes of Health
Notice of Changes to Funding Opportunities
-
Notice of Participation of the National Institute on Aging in PAR-25-292, "The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)"
(NOT-AG-24-088)National Institute on Aging
-
Notice of Early Expiration of "Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies To Improve Transplantation Outcomes", NOT-AI-21-080
(NOT-AI-25-002)National Institute of Allergy and Infectious Diseases
-
Notice of Correction to PAR-25-240: Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
(NOT-CA-25-014)National Cancer Institute
-
Notice of Early Expiration and Reissue of RFA-DA-25-056, "Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)"
(NOT-DA-24-061)National Institute on Drug Abuse
-
Notice of Participation in PAR-23-237, "Enhancement and Management of Established Biomedical Data Repositories and Knowledgebases (U24 Clinical Trial Not Allowed)"
(NOT-DC-25-016)National Institute on Deafness and Other Communication Disorders
-
NEI Notice of Participation in NOT-OD-25-009, "Notice of Special Interest (NOSI): Availability of Administrative Supplements for Childcare Costs for Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellows"
(NOT-EY-25-001)National Eye Institute
-
Notice of Correction for RFA-MD-24-010, Environmental Health Disparities Centers (P50) Clinical Trial Optional
(NOT-MD-25-006)National Institute on Minority Health and Health Disparities
-
Notice to Extend K01 Notice of Funding Opportunity
(NOT-OH-25-003)National Institute for Occupational Safety and Health
-
Notice to Extend R01/R03/R21 Notices of Funding Opportunities
(NOT-OH-25-004)National Institute for Occupational Safety and Health
Notices of Intent to Publish
-
Notice of Intent to Publish a Notice of Funding Opportunity for Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
(NOT-AG-24-084)National Institute on Aging
-
Notice of Intent to Publish a Notice of Funding Opportunity for Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
(NOT-AG-24-085)National Institute on Aging
-
Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 Independent Clinical Trial Not Allowed)
(NOT-CA-25-016)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Academic Career Excellence (ACE) Award (K32 - Independent Clinical Trial Required)
(NOT-CA-25-017)National Cancer Institute
-
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
(NOT-EY-25-002)National Eye Institute
Notices of Special Interest
-
Notice of Special Interest (NOSI): Somatic Cell Gene Editing Therapies to Improve Transplantation Outcomes
(NOT-AI-24-085)National Institute of Allergy and Infectious DiseasesNational Institute of Diabetes and Digestive and Kidney Diseases
Funding Opportunities
-
NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
(PAR-24-286)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
(PAR-24-317)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
(PAR-24-318)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
(PAR-24-319)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
(PAR-24-320)National Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
(PAR-24-330)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Cancer InstituteNational Heart, Lung, and Blood InstituteNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeOffice of Behavioral and Social Sciences ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
(PAR-25-025)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
(PAR-25-026)National Heart, Lung, and Blood InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
(PAR-25-100)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
(PAR-25-188)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
(PAR-25-215)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
(PAR-25-216)National Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Multiple dates, see announcement.
-
NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
(PAR-25-239)National Institute of Dental and Craniofacial ResearchApplication Receipt Date(s): Multiple dates, see announcement.
-
Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
(PAR-25-242)John E. Fogarty International CenterNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Institute of Mental HealthNational Institute of Biomedical Imaging and BioengineeringOffice of Research on Women's HealthOffice of Dietary SupplementsApplication Receipt Date(s): Multiple dates, see announcement.
-
NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
(PAR-25-251)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Multiple dates, see announcement.
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
(PAR-25-265)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): Multiple dates, see announcement.
-
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
(PAR-25-266)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): Multiple dates, see announcement.
-
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
(PAR-25-269)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
(PAR-25-270)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
(PAR-25-271)National Center for Complementary and Integrative HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
(PAR-25-297)National Institute on AgingApplication Receipt Date(s): Multiple dates, see announcement.
-
Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
(PAR-25-299)National Institute on Minority Health and Health DisparitiesNational Institute on Alcohol Abuse and AlcoholismNational Cancer InstituteApplication Receipt Date(s): Multiple dates, see announcement.
-
Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
(PAR-25-300)National Institute of Allergy and Infectious DiseasesApplication Receipt Date(s): Not Applicable
-
Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
(PAR-25-310)National Institute of Mental HealthApplication Receipt Date(s): Multiple dates, see announcement.
-
Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)
(RFA-AG-24-049)National Institute on AgingApplication Receipt Date(s): February 28, 2025
-
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required)
(RFA-DA-26-003)National Institute on Drug AbuseOffice of Research on Women's HealthOffice of AIDS ResearchNational Institute on Minority Health and Health DisparitiesApplication Receipt Date(s): Not Applicable
-
Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required)
(RFA-DA-26-004)National Institute on Drug AbuseOffice of Research on Women's HealthOffice of AIDS ResearchApplication Receipt Date(s): Not Applicable
-
Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
(RFA-DA-26-055)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
(RFA-DA-26-056)National Institute on Drug AbuseApplication Receipt Date(s): Multiple dates, see announcement.
-
Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed)
(RFA-ES-25-003)National Institute of Environmental Health SciencesApplication Receipt Date(s): Multiple dates, see announcement.
-
Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional)
(RFA-HD-26-005)Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentApplication Receipt Date(s): March 19, 2025
-
Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
(RFA-HG-25-007)National Human Genome Research InstituteNational Institute on AgingNational Cancer InstituteApplication Receipt Date(s): March 03, 2025
-
High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
(RFA-OD-25-001)Office of Disease PreventionNational Cancer InstituteNational Institute on Drug AbuseNational Heart, Lung, and Blood InstituteApplication Receipt Date(s): June 06, 2025
-
In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
(RFA-RM-24-012)Office of Strategic Coordination (Common Fund)Application Receipt Date(s): March 07, 2025
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
(RFA-TR-25-002)National Center for Advancing Translational SciencesNational Center for Advancing Translational SciencesApplication Receipt Date(s): Multiple dates, see announcement.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: February 7, 2025
For technical issues E-mail OER Webmaster